Document is current
Any future updates will be listed below
-
Authors
Burghout, Kimberly S. T.
Weijer, Jurre A. J.
Evers, Alize C.
Breimer, Gerben E.
van Rossem, Jeroen N.
Peferoen, Laura A. N.
Bloemena, Elisabeth
Koppes, Sjors A.
van Dis, Vera
Verdijk, Robert M.
van Engen-van Grunsven, Ilse
Doeleman, Thom
van den Hout, Mari F. C. M.
van der Vegt, Bert
Doff, Jan Johannes
Hazelbag, Hans Marten
Smit, Laura A.
de Cuba, Erienne M. V.
Ooft, Marc L.
Rupp, Niels J.
Steeghs, Elisabeth M. P.
de Ridder, Mischa
de Bree, Remco
Slingerland, Marije
Smit, Vincent T. H. B. M.
van Egmond, Sylvia L.
Cohen, Danielle
-
Funding
Funding for this research was provided by:
Hanarth Fonds
- License Information
-
More Information
Article History
Received: 17 January 2026
Accepted: 6 March 2026
First Online: 5 June 2026
Declarations
:
: BvdV reports honoraria received by UMCG for expertise or scientific advisory board/consultancy roles (upon request): Visiopharm, Philips, MSD/Merck, Daiichi-Sankyo/AstraZeneca; and speaker’s fees from MSD/Merck. Unrestricted research grants from OWKIN, GE Healthcare, Roche, and IBEX. Personal fees were received from DEKRA. All activities are unrelated to the current manuscript. NJR discloses the receipt of a travel grant from Roche Diagnostics, and an advisory board function for AbbVie AG, both outside the scope of the current publication. All other authors declare no conflict of interest.
